4-(4-amino-2-methylquinolin-5-yl)oxy-1-cyclobutyl-3,3-dimethylbutan-2-one;N-[4-(4-amino-2-methylquinolin-5-yl)oxycyclohexyl]-2-methylpropanamide;N-[1-(4-amino-2-methylquinolin-5-yl)oxy-2-methylpropan-2-yl]cyclobutanecarboxamide;N-[1-(4-amino-2-methylquinolin-5-yl)oxy-2-methylpropan-2-yl]cyclohexanecarboxamide;N-[1-(4-amino-2-methylquinolin-5-yl)oxy-2-methylpropan-2-yl]-3-methylbutanamide;N-[1-(4-amino-2-methylquinolin-5-yl)oxy-2-methylpropan-2-yl]-2-methylpropanamide;N-[1-(4-amino-2-methylquinolin-5-yl)oxy-2-methylpropan-2-yl]propanamide;1-[4-(4-amino-2-methylquinolin-5-yl)oxypiperidin-1-yl]-2-methylpropan-1-one;octakis(carbon dioxide)

C161H207N23O32 — CID 158470521

IUPAC4-(4-amino-2-methylquinolin-5-yl)oxy-1-cyclobutyl-3,3-dimethylbutan-2-one;N-[4-(4-amino-2-methylquinolin-5-yl)oxycyclohexyl]-2-methylpropanamide;N-[1-(4-amino-2-methylquinolin-5-yl)oxy-2-methylpropan-2-yl]cyclobutanecarboxamide;N-[1-(4-amino-2-methylquinolin-5-yl)oxy-2-methylpropan-2-yl]cyclohexanecarboxamide;N-[1-(4-amino-2-methylquinolin-5-yl)oxy-2-methylpropan-2-yl]-3-methylbutanamide;N-[1-(4-amino-2-methylquinolin-5-yl)oxy-2-methylpropan-2-yl]-2-methylpropanamide;N-[1-(4-amino-2-methylquinolin-5-yl)oxy-2-methylpropan-2-yl]propanamide;1-[4-(4-amino-2-methylquinolin-5-yl)oxypiperidin-1-yl]-2-methylpropan-1-one;octakis(carbon dioxide)
SMILESCCC(=O)NC(C)(C)COc1cccc2nc(C)cc(N)c12.Cc1cc(N)c2c(OC3CCC(NC(=O)C(C)C)CC3)cccc2n1.Cc1cc(N)c2c(OC3CCN(C(=O)C(C)C)CC3)cccc2n1.Cc1cc(N)c2c(OCC(C)(C)C(=O)CC3CCC3)cccc2n1.Cc1cc(N)c2c(OCC(C)(C)NC(=O)C(C)C)cccc2n1.Cc1cc(N)c2c(OCC(C)(C)NC(=O)C3CCC3)cccc2n1.Cc1cc(N)c2c(OCC(C)(C)NC(=O)C3CCCCC3)cccc2n1.Cc1cc(N)c2c(OCC(C)(C)NC(=O)CC(C)C)cccc2n1.O=C=O.O=C=O.O=C=O.O=C=O.O=C=O.O=C=O.O=C=O.O=C=O
InChIInChI=1S/C21H29N3O2.C20H27N3O2.C20H26N2O2.2C19H25N3O2.C19H27N3O2.C18H25N3O2.C17H23N3O2.8CO2/c1-14-12-16(22)19-17(23-14)10-7-11-18(19)26-13-21(2,3)24-20(25)15-8-5-4-6-9-15;1-12(2)20(24)23-14-7-9-15(10-8-14)25-18-6-4-5-17-19(18)16(21)11-13(3)22-17;1-13-10-15(21)19-16(22-13)8-5-9-17(19)24-12-20(2,3)18(23)11-14-6-4-7-14;1-12-10-14(20)17-15(21-12)8-5-9-16(17)24-11-19(2,3)22-18(23)13-6-4-7-13;1-12(2)19(23)22-9-7-14(8-10-22)24-17-6-4-5-16-18(17)15(20)11-13(3)21-16;1-12(2)9-17(23)22-19(4,5)11-24-16-8-6-7-15-18(16)14(20)10-13(3)21-15;1-11(2)17(22)21-18(4,5)10-23-15-8-6-7-14-16(15)13(19)9-12(3)20-14;1-5-15(21)20-17(3,4)10-22-14-8-6-7-13-16(14)12(18)9-11(2)19-13;8*2-1-3/h7,10-12,15H,4-6,8-9,13H2,1-3H3,(H2,22,23)(H,24,25);4-6,11-12,14-15H,7-10H2,1-3H3,(H2,21,22)(H,23,24);5,8-10,14H,4,6-7,11-12H2,1-3H3,(H2,21,22);5,8-10,13H,4,6-7,11H2,1-3H3,(H2,20,21)(H,22,23);4-6,11-12,14H,7-10H2,1-3H3,(H2,20,21);6-8,10,12H,9,11H2,1-5H3,(H2,20,21)(H,22,23);6-9,11H,10H2,1-5H3,(H2,19,20)(H,21,22);6-9H,5,10H2,1-4H3,(H2,18,19)(H,20,21);;;;;;;;
InChIKeyHGHFNTHYXRFODD-UHFFFAOYSA-N
MW2976.56 g/mol
LogP22.85
Rot. Bonds39

About 4-(4-amino-2-methylquinolin-5-yl)oxy-1-cyclobutyl-3,3-dimethylbutan-2-one;N-[4-(4-amino-2-methylquinolin-5-yl)oxycyclohexyl]-2-methylpropanamide;N-[1-(4-amino-2-methylquinolin-5-yl)oxy-2-methylpropan-2-yl]cyclobutanecarboxamide;N-[1-(4-amino-2-methylquinolin-5-yl)oxy-2-methylpropan-2-yl]cyclohexanecarboxamide;N-[1-(4-amino-2-methylquinolin-5-yl)oxy-2-methylpropan-2-yl]-3-methylbutanamide;N-[1-(4-amino-2-methylquinolin-5-yl)oxy-2-methylpropan-2-yl]-2-methylpropanamide;N-[1-(4-amino-2-methylquinolin-5-yl)oxy-2-methylpropan-2-yl]propanamide;1-[4-(4-amino-2-methylquinolin-5-yl)oxypiperidin-1-yl]-2-methylpropan-1-one;octakis(carbon dioxide)

4-(4-amino-2-methylquinolin-5-yl)oxy-1-cyclobutyl-3,3-dimethylbutan-2-one;N-[4-(4-amino-2-methylquinolin-5-yl)oxycyclohexyl]-2-methylpropanamide;N-[1-(4-amino-2-methylquinolin-5-yl)oxy-2-methylpropan-2-yl]cyclobutanecarboxamide;N-[1-(4-amino-2-methylquinolin-5-yl)oxy-2-methylpropan-2-yl]cyclohexanecarboxamide;N-[1-(4-amino-2-methylquinolin-5-yl)oxy-2-methylpropan-2-yl]-3-methylbutanamide;N-[1-(4-amino-2-methylquinolin-5-yl)oxy-2-methylpropan-2-yl]-2-methylpropanamide;N-[1-(4-amino-2-methylquinolin-5-yl)oxy-2-methylpropan-2-yl]propanamide;1-[4-(4-amino-2-methylquinolin-5-yl)oxypiperidin-1-yl]-2-methylpropan-1-one;octakis(carbon dioxide) (PubChem CID 158470521) has the molecular formula C161H207N23O32 and a molecular weight of 2976.56 g/mol. Its IUPAC name is 4-(4-amino-2-methylquinolin-5-yl)oxy-1-cyclobutyl-3,3-dimethylbutan-2-one;N-[4-(4-amino-2-methylquinolin-5-yl)oxycyclohexyl]-2-methylpropanamide;N-[1-(4-amino-2-methylquinolin-5-yl)oxy-2-methylpropan-2-yl]cyclobutanecarboxamide;N-[1-(4-amino-2-methylquinolin-5-yl)oxy-2-methylpropan-2-yl]cyclohexanecarboxamide;N-[1-(4-amino-2-methylquinolin-5-yl)oxy-2-methylpropan-2-yl]-3-methylbutanamide;N-[1-(4-amino-2-methylquinolin-5-yl)oxy-2-methylpropan-2-yl]-2-methylpropanamide;N-[1-(4-amino-2-methylquinolin-5-yl)oxy-2-methylpropan-2-yl]propanamide;1-[4-(4-amino-2-methylquinolin-5-yl)oxypiperidin-1-yl]-2-methylpropan-1-one;octakis(carbon dioxide).

Molecular Properties

Compound Name4-(4-amino-2-methylquinolin-5-yl)oxy-1-cyclobutyl-3,3-dimethylbutan-2-one;N-[4-(4-amino-2-methylquinolin-5-yl)oxycyclohexyl]-2-methylpropanamide;N-[1-(4-amino-2-methylquinolin-5-yl)oxy-2-methylpropan-2-yl]cyclobutanecarboxamide;N-[1-(4-amino-2-methylquinolin-5-yl)oxy-2-methylpropan-2-yl]cyclohexanecarboxamide;N-[1-(4-amino-2-methylquinolin-5-yl)oxy-2-methylpropan-2-yl]-3-methylbutanamide;N-[1-(4-amino-2-methylquinolin-5-yl)oxy-2-methylpropan-2-yl]-2-methylpropanamide;N-[1-(4-amino-2-methylquinolin-5-yl)oxy-2-methylpropan-2-yl]propanamide;1-[4-(4-amino-2-methylquinolin-5-yl)oxypiperidin-1-yl]-2-methylpropan-1-one;octakis(carbon dioxide)
PubChem CID158470521
Molecular FormulaC161H207N23O32
Molecular Weight2976.56 g/mol
Exact Mass2974.53
IUPAC Name4-(4-amino-2-methylquinolin-5-yl)oxy-1-cyclobutyl-3,3-dimethylbutan-2-one;N-[4-(4-amino-2-methylquinolin-5-yl)oxycyclohexyl]-2-methylpropanamide;N-[1-(4-amino-2-methylquinolin-5-yl)oxy-2-methylpropan-2-yl]cyclobutanecarboxamide;N-[1-(4-amino-2-methylquinolin-5-yl)oxy-2-methylpropan-2-yl]cyclohexanecarboxamide;N-[1-(4-amino-2-methylquinolin-5-yl)oxy-2-methylpropan-2-yl]-3-methylbutanamide;N-[1-(4-amino-2-methylquinolin-5-yl)oxy-2-methylpropan-2-yl]-2-methylpropanamide;N-[1-(4-amino-2-methylquinolin-5-yl)oxy-2-methylpropan-2-yl]propanamide;1-[4-(4-amino-2-methylquinolin-5-yl)oxypiperidin-1-yl]-2-methylpropan-1-one;octakis(carbon dioxide)
SMILESCCC(=O)NC(C)(C)COc1cccc2nc(C)cc(N)c12.Cc1cc(N)c2c(OC3CCC(NC(=O)C(C)C)CC3)cccc2n1.Cc1cc(N)c2c(OC3CCN(C(=O)C(C)C)CC3)cccc2n1.Cc1cc(N)c2c(OCC(C)(C)C(=O)CC3CCC3)cccc2n1.Cc1cc(N)c2c(OCC(C)(C)NC(=O)C(C)C)cccc2n1.Cc1cc(N)c2c(OCC(C)(C)NC(=O)C3CCC3)cccc2n1.Cc1cc(N)c2c(OCC(C)(C)NC(=O)C3CCCCC3)cccc2n1.Cc1cc(N)c2c(OCC(C)(C)NC(=O)CC(C)C)cccc2n1.O=C=O.O=C=O.O=C=O.O=C=O.O=C=O.O=C=O.O=C=O.O=C=O
InChIInChI=1S/C21H29N3O2.C20H27N3O2.C20H26N2O2.2C19H25N3O2.C19H27N3O2.C18H25N3O2.C17H23N3O2.8CO2/c1-14-12-16(22)19-17(23-14)10-7-11-18(19)26-13-21(2,3)24-20(25)15-8-5-4-6-9-15;1-12(2)20(24)23-14-7-9-15(10-8-14)25-18-6-4-5-17-19(18)16(21)11-13(3)22-17;1-13-10-15(21)19-16(22-13)8-5-9-17(19)24-12-20(2,3)18(23)11-14-6-4-7-14;1-12-10-14(20)17-15(21-12)8-5-9-16(17)24-11-19(2,3)22-18(23)13-6-4-7-13;1-12(2)19(23)22-9-7-14(8-10-22)24-17-6-4-5-16-18(17)15(20)11-13(3)21-16;1-12(2)9-17(23)22-19(4,5)11-24-16-8-6-7-15-18(16)14(20)10-13(3)21-15;1-11(2)17(22)21-18(4,5)10-23-15-8-6-7-14-16(15)13(19)9-12(3)20-14;1-5-15(21)20-17(3,4)10-22-14-8-6-7-13-16(14)12(18)9-11(2)19-13;8*2-1-3/h7,10-12,15H,4-6,8-9,13H2,1-3H3,(H2,22,23)(H,24,25);4-6,11-12,14-15H,7-10H2,1-3H3,(H2,21,22)(H,23,24);5,8-10,14H,4,6-7,11-12H2,1-3H3,(H2,21,22);5,8-10,13H,4,6-7,11H2,1-3H3,(H2,20,21)(H,22,23);4-6,11-12,14H,7-10H2,1-3H3,(H2,20,21);6-8,10,12H,9,11H2,1-5H3,(H2,20,21)(H,22,23);6-9,11H,10H2,1-5H3,(H2,19,20)(H,21,22);6-9H,5,10H2,1-4H3,(H2,18,19)(H,20,21);;;;;;;;
InChIKeyHGHFNTHYXRFODD-UHFFFAOYSA-N
XLogP22.85
TPSA870.22 Ų
H-Bond Donors14
H-Bond Acceptors48
Rotatable Bonds39
Heavy Atoms216
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002976.56
LogP ≤ 522.85
H-Bond Donors ≤ 514
H-Bond Acceptors ≤ 1048

Analyze 4-(4-amino-2-methylquinolin-5-yl)oxy-1-cyclobutyl-3,3-dimethylbutan-2-one;N-[4-(4-amino-2-methylquinolin-5-yl)oxycyclohexyl]-2-methylpropanamide;N-[1-(4-amino-2-methylquinolin-5-yl)oxy-2-methylpropan-2-yl]cyclobutanecarboxamide;N-[1-(4-amino-2-methylquinolin-5-yl)oxy-2-methylpropan-2-yl]cyclohexanecarboxamide;N-[1-(4-amino-2-methylquinolin-5-yl)oxy-2-methylpropan-2-yl]-3-methylbutanamide;N-[1-(4-amino-2-methylquinolin-5-yl)oxy-2-methylpropan-2-yl]-2-methylpropanamide;N-[1-(4-amino-2-methylquinolin-5-yl)oxy-2-methylpropan-2-yl]propanamide;1-[4-(4-amino-2-methylquinolin-5-yl)oxypiperidin-1-yl]-2-methylpropan-1-one;octakis(carbon dioxide) with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 4-(4-amino-2-methylquinolin-5-yl)oxy-1-cyclobutyl-3,3-dimethylbutan-2-one;N-[4-(4-amino-2-methylquinolin-5-yl)oxycyclohexyl]-2-methylpropanamide;N-[1-(4-amino-2-methylquinolin-5-yl)oxy-2-methylpropan-2-yl]cyclobutanecarboxamide;N-[1-(4-amino-2-methylquinolin-5-yl)oxy-2-methylpropan-2-yl]cyclohexanecarboxamide;N-[1-(4-amino-2-methylquinolin-5-yl)oxy-2-methylpropan-2-yl]-3-methylbutanamide;N-[1-(4-amino-2-methylquinolin-5-yl)oxy-2-methylpropan-2-yl]-2-methylpropanamide;N-[1-(4-amino-2-methylquinolin-5-yl)oxy-2-methylpropan-2-yl]propanamide;1-[4-(4-amino-2-methylquinolin-5-yl)oxypiperidin-1-yl]-2-methylpropan-1-one;octakis(carbon dioxide)?
The IUPAC name of 4-(4-amino-2-methylquinolin-5-yl)oxy-1-cyclobutyl-3,3-dimethylbutan-2-one;N-[4-(4-amino-2-methylquinolin-5-yl)oxycyclohexyl]-2-methylpropanamide;N-[1-(4-amino-2-methylquinolin-5-yl)oxy-2-methylpropan-2-yl]cyclobutanecarboxamide;N-[1-(4-amino-2-methylquinolin-5-yl)oxy-2-methylpropan-2-yl]cyclohexanecarboxamide;N-[1-(4-amino-2-methylquinolin-5-yl)oxy-2-methylpropan-2-yl]-3-methylbutanamide;N-[1-(4-amino-2-methylquinolin-5-yl)oxy-2-methylpropan-2-yl]-2-methylpropanamide;N-[1-(4-amino-2-methylquinolin-5-yl)oxy-2-methylpropan-2-yl]propanamide;1-[4-(4-amino-2-methylquinolin-5-yl)oxypiperidin-1-yl]-2-methylpropan-1-one;octakis(carbon dioxide) (CID 158470521) is 4-(4-amino-2-methylquinolin-5-yl)oxy-1-cyclobutyl-3,3-dimethylbutan-2-one;N-[4-(4-amino-2-methylquinolin-5-yl)oxycyclohexyl]-2-methylpropanamide;N-[1-(4-amino-2-methylquinolin-5-yl)oxy-2-methylpropan-2-yl]cyclobutanecarboxamide;N-[1-(4-amino-2-methylquinolin-5-yl)oxy-2-methylpropan-2-yl]cyclohexanecarboxamide;N-[1-(4-amino-2-methylquinolin-5-yl)oxy-2-methylpropan-2-yl]-3-methylbutanamide;N-[1-(4-amino-2-methylquinolin-5-yl)oxy-2-methylpropan-2-yl]-2-methylpropanamide;N-[1-(4-amino-2-methylquinolin-5-yl)oxy-2-methylpropan-2-yl]propanamide;1-[4-(4-amino-2-methylquinolin-5-yl)oxypiperidin-1-yl]-2-methylpropan-1-one;octakis(carbon dioxide).
What is the SMILES notation for 4-(4-amino-2-methylquinolin-5-yl)oxy-1-cyclobutyl-3,3-dimethylbutan-2-one;N-[4-(4-amino-2-methylquinolin-5-yl)oxycyclohexyl]-2-methylpropanamide;N-[1-(4-amino-2-methylquinolin-5-yl)oxy-2-methylpropan-2-yl]cyclobutanecarboxamide;N-[1-(4-amino-2-methylquinolin-5-yl)oxy-2-methylpropan-2-yl]cyclohexanecarboxamide;N-[1-(4-amino-2-methylquinolin-5-yl)oxy-2-methylpropan-2-yl]-3-methylbutanamide;N-[1-(4-amino-2-methylquinolin-5-yl)oxy-2-methylpropan-2-yl]-2-methylpropanamide;N-[1-(4-amino-2-methylquinolin-5-yl)oxy-2-methylpropan-2-yl]propanamide;1-[4-(4-amino-2-methylquinolin-5-yl)oxypiperidin-1-yl]-2-methylpropan-1-one;octakis(carbon dioxide)?
The canonical SMILES for 4-(4-amino-2-methylquinolin-5-yl)oxy-1-cyclobutyl-3,3-dimethylbutan-2-one;N-[4-(4-amino-2-methylquinolin-5-yl)oxycyclohexyl]-2-methylpropanamide;N-[1-(4-amino-2-methylquinolin-5-yl)oxy-2-methylpropan-2-yl]cyclobutanecarboxamide;N-[1-(4-amino-2-methylquinolin-5-yl)oxy-2-methylpropan-2-yl]cyclohexanecarboxamide;N-[1-(4-amino-2-methylquinolin-5-yl)oxy-2-methylpropan-2-yl]-3-methylbutanamide;N-[1-(4-amino-2-methylquinolin-5-yl)oxy-2-methylpropan-2-yl]-2-methylpropanamide;N-[1-(4-amino-2-methylquinolin-5-yl)oxy-2-methylpropan-2-yl]propanamide;1-[4-(4-amino-2-methylquinolin-5-yl)oxypiperidin-1-yl]-2-methylpropan-1-one;octakis(carbon dioxide) is CCC(=O)NC(C)(C)COc1cccc2nc(C)cc(N)c12.Cc1cc(N)c2c(OC3CCC(NC(=O)C(C)C)CC3)cccc2n1.Cc1cc(N)c2c(OC3CCN(C(=O)C(C)C)CC3)cccc2n1.Cc1cc(N)c2c(OCC(C)(C)C(=O)CC3CCC3)cccc2n1.Cc1cc(N)c2c(OCC(C)(C)NC(=O)C(C)C)cccc2n1.Cc1cc(N)c2c(OCC(C)(C)NC(=O)C3CCC3)cccc2n1.Cc1cc(N)c2c(OCC(C)(C)NC(=O)C3CCCCC3)cccc2n1.Cc1cc(N)c2c(OCC(C)(C)NC(=O)CC(C)C)cccc2n1.O=C=O.O=C=O.O=C=O.O=C=O.O=C=O.O=C=O.O=C=O.O=C=O.
What is the InChIKey of 4-(4-amino-2-methylquinolin-5-yl)oxy-1-cyclobutyl-3,3-dimethylbutan-2-one;N-[4-(4-amino-2-methylquinolin-5-yl)oxycyclohexyl]-2-methylpropanamide;N-[1-(4-amino-2-methylquinolin-5-yl)oxy-2-methylpropan-2-yl]cyclobutanecarboxamide;N-[1-(4-amino-2-methylquinolin-5-yl)oxy-2-methylpropan-2-yl]cyclohexanecarboxamide;N-[1-(4-amino-2-methylquinolin-5-yl)oxy-2-methylpropan-2-yl]-3-methylbutanamide;N-[1-(4-amino-2-methylquinolin-5-yl)oxy-2-methylpropan-2-yl]-2-methylpropanamide;N-[1-(4-amino-2-methylquinolin-5-yl)oxy-2-methylpropan-2-yl]propanamide;1-[4-(4-amino-2-methylquinolin-5-yl)oxypiperidin-1-yl]-2-methylpropan-1-one;octakis(carbon dioxide)?
The InChIKey is HGHFNTHYXRFODD-UHFFFAOYSA-N. The full InChI is InChI=1S/C21H29N3O2.C20H27N3O2.C20H26N2O2.2C19H25N3O2.C19H27N3O2.C18H25N3O2.C17H23N3O2.8CO2/c1-14-12-16(22)19-17(23-14)10-7-11-18(19)26-13-21(2,3)24-20(25)15-8-5-4-6-9-15;1-12(2)20(24)23-14-7-9-15(10-8-14)25-18-6-4-5-17-19(18)16(21)11-13(3)22-17;1-13-10-15(21)19-16(22-13)8-5-9-17(19)24-12-20(2,3)18(23)11-14-6-4-7-14;1-12-10-14(20)17-15(21-12)8-5-9-16(17)24-11-19(2,3)22-18(23)13-6-4-7-13;1-12(2)19(23)22-9-7-14(8-10-22)24-17-6-4-5-16-18(17)15(20)11-13(3)21-16;1-12(2)9-17(23)22-19(4,5)11-24-16-8-6-7-15-18(16)14(20)10-13(3)21-15;1-11(2)17(22)21-18(4,5)10-23-15-8-6-7-14-16(15)13(19)9-12(3)20-14;1-5-15(21)20-17(3,4)10-22-14-8-6-7-13-16(14)12(18)9-11(2)19-13;8*2-1-3/h7,10-12,15H,4-6,8-9,13H2,1-3H3,(H2,22,23)(H,24,25);4-6,11-12,14-15H,7-10H2,1-3H3,(H2,21,22)(H,23,24);5,8-10,14H,4,6-7,11-12H2,1-3H3,(H2,21,22);5,8-10,13H,4,6-7,11H2,1-3H3,(H2,20,21)(H,22,23);4-6,11-12,14H,7-10H2,1-3H3,(H2,20,21);6-8,10,12H,9,11H2,1-5H3,(H2,20,21)(H,22,23);6-9,11H,10H2,1-5H3,(H2,19,20)(H,21,22);6-9H,5,10H2,1-4H3,(H2,18,19)(H,20,21);;;;;;;;.
What are the key properties of 4-(4-amino-2-methylquinolin-5-yl)oxy-1-cyclobutyl-3,3-dimethylbutan-2-one;N-[4-(4-amino-2-methylquinolin-5-yl)oxycyclohexyl]-2-methylpropanamide;N-[1-(4-amino-2-methylquinolin-5-yl)oxy-2-methylpropan-2-yl]cyclobutanecarboxamide;N-[1-(4-amino-2-methylquinolin-5-yl)oxy-2-methylpropan-2-yl]cyclohexanecarboxamide;N-[1-(4-amino-2-methylquinolin-5-yl)oxy-2-methylpropan-2-yl]-3-methylbutanamide;N-[1-(4-amino-2-methylquinolin-5-yl)oxy-2-methylpropan-2-yl]-2-methylpropanamide;N-[1-(4-amino-2-methylquinolin-5-yl)oxy-2-methylpropan-2-yl]propanamide;1-[4-(4-amino-2-methylquinolin-5-yl)oxypiperidin-1-yl]-2-methylpropan-1-one;octakis(carbon dioxide)?
4-(4-amino-2-methylquinolin-5-yl)oxy-1-cyclobutyl-3,3-dimethylbutan-2-one;N-[4-(4-amino-2-methylquinolin-5-yl)oxycyclohexyl]-2-methylpropanamide;N-[1-(4-amino-2-methylquinolin-5-yl)oxy-2-methylpropan-2-yl]cyclobutanecarboxamide;N-[1-(4-amino-2-methylquinolin-5-yl)oxy-2-methylpropan-2-yl]cyclohexanecarboxamide;N-[1-(4-amino-2-methylquinolin-5-yl)oxy-2-methylpropan-2-yl]-3-methylbutanamide;N-[1-(4-amino-2-methylquinolin-5-yl)oxy-2-methylpropan-2-yl]-2-methylpropanamide;N-[1-(4-amino-2-methylquinolin-5-yl)oxy-2-methylpropan-2-yl]propanamide;1-[4-(4-amino-2-methylquinolin-5-yl)oxypiperidin-1-yl]-2-methylpropan-1-one;octakis(carbon dioxide) has a molecular weight of 2976.56 g/mol, XLogP of 22.85, 39 rotatable bonds, 14 hydrogen bond donors, and 48 hydrogen bond acceptors.
Where does this data come from?
All data for 4-(4-amino-2-methylquinolin-5-yl)oxy-1-cyclobutyl-3,3-dimethylbutan-2-one;N-[4-(4-amino-2-methylquinolin-5-yl)oxycyclohexyl]-2-methylpropanamide;N-[1-(4-amino-2-methylquinolin-5-yl)oxy-2-methylpropan-2-yl]cyclobutanecarboxamide;N-[1-(4-amino-2-methylquinolin-5-yl)oxy-2-methylpropan-2-yl]cyclohexanecarboxamide;N-[1-(4-amino-2-methylquinolin-5-yl)oxy-2-methylpropan-2-yl]-3-methylbutanamide;N-[1-(4-amino-2-methylquinolin-5-yl)oxy-2-methylpropan-2-yl]-2-methylpropanamide;N-[1-(4-amino-2-methylquinolin-5-yl)oxy-2-methylpropan-2-yl]propanamide;1-[4-(4-amino-2-methylquinolin-5-yl)oxypiperidin-1-yl]-2-methylpropan-1-one;octakis(carbon dioxide) is sourced from PubChem (CID 158470521), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).